- Motley Fool•15 hours ago
Looking for cheap biotech stocks you can buy now? These three may be bargains.
- Barrons.com•yesterdayThis Weekend's Barron's: Dow Rally Has Legs -- 20,000 Next Stop ~ Quarterly Penta Issue ~ Goodyear Poised for a Great Year ~ Insights from the London Hedge Fund Conference
The Dow Strikes Back The Dow Jones Industrial Average is set to push past the 20,000 mark any day now—and Barron’s thinks there will be more gains for the Dow in 2017 as Donald Trump enacts policies favorable to industrial and financial companies, which are heavily represented in the index.
Many investors hang on to Johnson & Johnson shares for the same reason they stock their cabinets with the company’s Band-Aids and baby shampoo: comfort and safety. J&J’s shares (JNJ) are up 8% this year, to a recent $111, but down 5% since Donald J. Trump’s election. Trump has vowed to reduce drug prices, but J&J is less susceptible to changes in pricing than its peers.
JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||112.17 x 300|
|Ask||112.39 x 400|
|Day's Range||111.20 - 112.43|
|52 Week Range||94.28 - 126.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||19.71|
|Dividend & Yield||3.20 (2.86%)|
|1y Target Est||N/A|